231 related articles for article (PubMed ID: 26136852)
1. Vintafolide: a novel targeted therapy for the treatment of folate receptor expressing tumors.
Vergote I; Leamon CP
Ther Adv Med Oncol; 2015 Jul; 7(4):206-18. PubMed ID: 26136852
[TBL] [Abstract][Full Text] [Related]
2. The folate receptor as a rational therapeutic target for personalized cancer treatment.
Assaraf YG; Leamon CP; Reddy JA
Drug Resist Updat; 2014; 17(4-6):89-95. PubMed ID: 25457975
[TBL] [Abstract][Full Text] [Related]
3. Targeting the folate receptor: diagnostic and therapeutic approaches to personalize cancer treatments.
Ledermann JA; Canevari S; Thigpen T
Ann Oncol; 2015 Oct; 26(10):2034-43. PubMed ID: 26063635
[TBL] [Abstract][Full Text] [Related]
4. Rational combination therapy of vintafolide (EC145) with commonly used chemotherapeutic drugs.
Reddy JA; Dorton R; Bloomfield A; Nelson M; Vetzel M; Guan J; Leamon CP
Clin Cancer Res; 2014 Apr; 20(8):2104-14. PubMed ID: 24429878
[TBL] [Abstract][Full Text] [Related]
5. High Levels of Expression of P-glycoprotein/Multidrug Resistance Protein Result in Resistance to Vintafolide.
Guertin AD; O'Neil J; Stoeck A; Reddy JA; Cristescu R; Haines BB; Hinton MC; Dorton R; Bloomfield A; Nelson M; Vetzel M; Lejnine S; Nebozhyn M; Zhang T; Loboda A; Picard KL; Schmidt EV; Dussault I; Leamon CP
Mol Cancer Ther; 2016 Aug; 15(8):1998-2008. PubMed ID: 27256377
[TBL] [Abstract][Full Text] [Related]
6. Targeted drug delivery via folate receptors in recurrent ovarian cancer: a review.
Marchetti C; Palaia I; Giorgini M; De Medici C; Iadarola R; Vertechy L; Domenici L; Di Donato V; Tomao F; Muzii L; Benedetti Panici P
Onco Targets Ther; 2014; 7():1223-36. PubMed ID: 25031539
[TBL] [Abstract][Full Text] [Related]
7. Mirvetuximab Soravtansine (IMGN853), a Folate Receptor Alpha-Targeting Antibody-Drug Conjugate, Potentiates the Activity of Standard of Care Therapeutics in Ovarian Cancer Models.
Ponte JF; Ab O; Lanieri L; Lee J; Coccia J; Bartle LM; Themeles M; Zhou Y; Pinkas J; Ruiz-Soto R
Neoplasia; 2016 Dec; 18(12):775-784. PubMed ID: 27889646
[TBL] [Abstract][Full Text] [Related]
8. Folate and folate receptor alpha antagonists mechanism of action in ovarian cancer.
Walters CL; Arend RC; Armstrong DK; Naumann RW; Alvarez RD
Gynecol Oncol; 2013 Nov; 131(2):493-8. PubMed ID: 23863359
[TBL] [Abstract][Full Text] [Related]
9. Targeted treatment of folate receptor-positive platinum-resistant ovarian cancer and companion diagnostics, with specific focus on vintafolide and etarfolatide.
Serpe L; Gallicchio M; Canaparo R; Dosio F
Pharmgenomics Pers Med; 2014; 7():31-42. PubMed ID: 24516337
[TBL] [Abstract][Full Text] [Related]
10. Vintafolide (EC145) for the treatment of folate-receptor-α positive platinum-resistant ovarian cancer.
Ambrosio AJ; Suzin D; Palmer EL; Penson RT
Expert Rev Clin Pharmacol; 2014 Jul; 7(4):443-50. PubMed ID: 24742319
[TBL] [Abstract][Full Text] [Related]
11. Phase 1 dose-escalation study of mirvetuximab soravtansine (IMGN853), a folate receptor α-targeting antibody-drug conjugate, in patients with solid tumors.
Moore KN; Borghaei H; O'Malley DM; Jeong W; Seward SM; Bauer TM; Perez RP; Matulonis UA; Running KL; Zhang X; Ponte JF; Ruiz-Soto R; Birrer MJ
Cancer; 2017 Aug; 123(16):3080-3087. PubMed ID: 28440955
[TBL] [Abstract][Full Text] [Related]
12. Profile of vintafolide (EC145) and its use in the treatment of platinum-resistant ovarian cancer.
Luyckx M; Votino R; Squifflet JL; Baurain JF
Int J Womens Health; 2014; 6():351-8. PubMed ID: 24729732
[TBL] [Abstract][Full Text] [Related]
13. Role of the folate receptor in ovarian cancer treatment: evidence, mechanism, and clinical implications.
Vergote IB; Marth C; Coleman RL
Cancer Metastasis Rev; 2015 Mar; 34(1):41-52. PubMed ID: 25564455
[TBL] [Abstract][Full Text] [Related]
14. PRECEDENT: a randomized phase II trial comparing vintafolide (EC145) and pegylated liposomal doxorubicin (PLD) in combination versus PLD alone in patients with platinum-resistant ovarian cancer.
Naumann RW; Coleman RL; Burger RA; Sausville EA; Kutarska E; Ghamande SA; Gabrail NY; Depasquale SE; Nowara E; Gilbert L; Gersh RH; Teneriello MG; Harb WA; Konstantinopoulos PA; Penson RT; Symanowski JT; Lovejoy CD; Leamon CP; Morgenstern DE; Messmann RA
J Clin Oncol; 2013 Dec; 31(35):4400-6. PubMed ID: 24127448
[TBL] [Abstract][Full Text] [Related]
15. Folate Receptor α-Targeted
Heo GS; Detering L; Luehmann HP; Primeau T; Lee YS; Laforest R; Li S; Stec J; Lim KH; Lockhart AC; Liu Y
Mol Pharm; 2019 Sep; 16(9):3996-4006. PubMed ID: 31369274
[TBL] [Abstract][Full Text] [Related]
16. Imaging the folate receptor on cancer cells with 99mTc-etarfolatide: properties, clinical use, and future potential of folate receptor imaging.
Maurer AH; Elsinga P; Fanti S; Nguyen B; Oyen WJ; Weber WA
J Nucl Med; 2014 May; 55(5):701-4. PubMed ID: 24732155
[TBL] [Abstract][Full Text] [Related]
17. Clinical translation of folate receptor-targeted therapeutics.
Teng L; Xie J; Teng L; Lee RJ
Expert Opin Drug Deliv; 2012 Aug; 9(8):901-8. PubMed ID: 22663189
[TBL] [Abstract][Full Text] [Related]
18. Folate receptor alpha antagonists in preclinical and early stage clinical development for the treatment of epithelial ovarian cancer.
Bergamini A; Ferrero S; Leone Roberti Maggiore U; Scala C; Pella F; Vellone VG; Petrone M; Rabaiotti E; Cioffi R; Candiani M; Mangili G
Expert Opin Investig Drugs; 2016 Dec; 25(12):1405-1412. PubMed ID: 27797594
[TBL] [Abstract][Full Text] [Related]
19. Improved Intraoperative Detection of Ovarian Cancer by Folate Receptor Alpha Targeted Dual-Modality Imaging.
Hekman MCH; Boerman OC; Bos DL; Massuger LFAG; Weil S; Grasso L; Rybinski KA; Oosterwijk E; Mulders PFA; Rijpkema M
Mol Pharm; 2017 Oct; 14(10):3457-3463. PubMed ID: 28826214
[TBL] [Abstract][Full Text] [Related]
20. Folate-vinca alkaloid conjugates for cancer therapy: a structure-activity relationship.
Leamon CP; Vlahov IR; Reddy JA; Vetzel M; Santhapuram HK; You F; Bloomfield A; Dorton R; Nelson M; Kleindl P; Vaughn JF; Westrick E
Bioconjug Chem; 2014 Mar; 25(3):560-8. PubMed ID: 24564229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
